Y. Ohe

Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.

Y. Hosomi, Y. Fujita, K. Naoki, 2024, Clinical pharmacology and therapeutics.

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722

J. Gainor, K. Ichikado, J. Sylvester, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis

S. Nomura, H. Horinouchi, Y. Shinno, 2024, Journal of cancer research and clinical oncology.

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

T. Mitsudomi, K. Kiura, H. Uramoto, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study

M. Maemondo, J. Tanizaki, S. Kitazono, 2024, Japanese journal of clinical oncology.

Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report.

R. Toyozawa, T. Tokito, Y. Shiraishi, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations

Amina Bolatkan, M. Miyake, Hirokazu Watanabe, 2024, Molecular cancer.

Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability

K. Shiraishi, Ken Asada, Ken Takasawa, 2024, Experimental & molecular medicine.

Nonreversed great saphenous vein grafts for vascular reconstruction after resection of lower-limb sarcoma.

S. Miyamoto, Masaki Arikawa, Daisuke Kageyama, 2024, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study.

N. Fujimoto, Ayumi Akamatsu, Chikara Honda, 2024, Japanese journal of clinical oncology.

Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.

Y. Shinno, Y. Ohe, 2023, Japanese journal of clinical oncology.